Skip to main content
. 2009 Nov 17;6:35. doi: 10.1186/1742-2094-6-35

Table 1.

Brain mRNA expression of complement components in APP23 and non-transgenic controls at 24 months

pathway/function control mice ± SEM APP23 ± SEM p (2 tailed t-test) increase APP23
C1q classical pathway 89'040 ± 4'788 189'896 ± 7'721 0.000000006

C4 classical pathway 10'042 ± 1'104 11'016 ± 1'754 0.64

factor B alternative pathway 647 ± 92 1'029 ± 164 0.06 1.6×

C3 all pathways 3'317 ± 114 10'550 ± 1'507 0.0007 3

C5 terminal sequence 117 ± 11 128 ± 12 0.51

C6 terminal sequence 13
(below limit of quantification)
43
(below limit of quantification)
- -

C8a terminal sequence not detectable not detectable - -

C8b terminal sequence 32
(below limit of quantification)
46
(below limit of quantification)
- -

C9 terminal sequence not detectable not detectable - -

Crry inhibitor all pathways 48'546 ± 4'156 49'891 ± 3'120 0.80

MCP inhibitor all pathways 20
(below limit of quantification)
37
(below limit of quantification)
- -

factor H inhibitor alternative pathway 14'756 ± 723 21'509 ± 913 0.00001 1.5×

Values are given as arbitrary units.